Table 1 Characteristics of studies included in the systematic review of gastric cancer incidence in patients with gastric atrophy
From: Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review
First author (Year) [reference] | Country | Study design | Indication(s) for endoscopy | Study follow up period | Outcome source | Number of patients in cohort | Male (%) | Mean age (years) | Follow-up (years) [mean/median] | HP* positive (%) |
|---|---|---|---|---|---|---|---|---|---|---|
González (2016) [38] | Spain | Retrospective cohort | NR* | 1995–2013 | Pathology records, clinical records, endoscopy | 156 | 46 | 49 | 12 (mean) | 80 |
Inoue (2000) [10] | Japan | Prospective cohort | NR* | 1985–1999 | Hospital records, Cancer registry, mail survey | 4397 | 48 | 50 | 10 (mean) | NR* |
Lahner (2015) [11] | Italy | Prospective cohort | Surveillance programme | 1992–2009 | Endoscopy | 200 | 33 | 55 | 7.5 (median) | NR* |
Siurala (1974) [35] | Finland | Prospective cohort | NR* | 1950–1973 | Endoscopy | 116 | NR* | 64 | 21 (mean) | NR* |
Song (2015) [36] | Sweden | Retrospective cohort | Dyspepsia | 1979–2011 | Endoscopy, Cancer registry, ONS* | 14,285 | 55 | 60 | 10.1 (mean) | NR* |
Takata (2007) [25] | Japan | Prospective cohort | NR* | 1991–2001 | NR* | 101 | 58 | 56 | 5.2 (mean) | NR* |
Tatsuta (1993) [8] | Japan | Retrospective cohort | NR* | 1968–1976 | Cancer registry, pathology database | 194 | 80 | NR* | 19 (mean) | 100 |
Vannella (2010) [17] | Italy | Prospective cohort | NR* | 1992–2008 | Endoscopy | 300 | 32 | 54 | 4.3 (median) | 6 |